Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
6.84M
-
Shares change
-
-701K
-
Total reported value, excl. options
-
$16.5M
-
Value change
-
-$8.55M
-
Number of buys
-
19
-
Number of sells
-
-26
-
Price
-
$2.42
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2018
57 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2018.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.84M shares
of 72.1M outstanding shares and own 9.49% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.6M shares), BlackRock Inc. (1.41M shares), COWEN INC. (851K shares), Redmile Group, LLC (738K shares), Tekla Capital Management LLC (497K shares), Vanguard Group Inc (292K shares), STATE STREET CORP (170K shares), NORTHERN TRUST CORP (139K shares), JPMORGAN CHASE & CO (134K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (98.4K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.